StockNews.com started coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a report issued on Tuesday morning. The firm issued a hold rating on the stock.
China Pharma Stock Performance
CPHI opened at $0.26 on Tuesday. China Pharma has a 1-year low of $0.17 and a 1-year high of $1.16. The stock’s 50 day simple moving average is $0.23 and its 200 day simple moving average is $0.25. The company has a debt-to-equity ratio of 0.19, a quick ratio of 0.24 and a current ratio of 0.84.
China Pharma (NYSE:CPHI – Get Free Report) last announced its earnings results on Wednesday, August 14th. The company reported ($0.09) earnings per share (EPS) for the quarter. China Pharma had a negative return on equity of 60.19% and a negative net margin of 70.47%. The business had revenue of $0.93 million for the quarter.
China Pharma Company Profile
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
Featured Articles
- Five stocks we like better than China Pharma
- 10 Best Airline Stocks to Buy
- Energy Vault Soars 100%: CEO Shares Why in MarketBeat Exclusive
- What Are the U.K. Market Holidays? How to Invest and Trade
- Meta’s Q3 Earnings Beat—Is This Dip a Golden Entry Opportunity?
- How Technical Indicators Can Help You Find Oversold Stocks
- Top Nuclear Stocks Thriving on Soaring Energy Demand
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
